CaƱedo, Angel Rose D.
HRN: 22-86-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2023
CEFUROXIME 750MG (VIAL)
04/14/2023
04/20/2023
IV
750mg
Q8
Multiple Soft Tissue Injuries
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes